GKI-1
CAS: 2444764-03-6
Rif. 3D-UXD76403
1mg | Fuori produzione | ||
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione |
Informazioni sul prodotto
GKI-1 is an analog inhibitor that has been shown to induce apoptosis in Chinese hamster ovary cells. It is a potent inhibitor of cyclin-dependent kinases and has been identified as a potential anticancer agent due to its ability to inhibit tumor growth. GKI-1 has been found to be effective against human cancer cells by targeting specific kinases involved in cell division and proliferation. This medicinal compound has promising potential for the development of new cancer therapeutics, as it selectively targets cancer cells while sparing healthy cells. With its unique properties, GKI-1 may prove to be an important tool in the fight against cancer.